Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
05/2006
05/02/2006US7037929 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/02/2006US7037919 novel nonsteroidal compounds and salts; have a specific and strong binding affinity for androgen receptors and exhibit AR agonism or antagonism; therapeutic effect on AR-mediated diseases such as male hypogonadism, male sexual dysfunction, anemia, aids, breast, prostate cancer
05/02/2006US7037918 Antidiabetic agents, cardiovascular disorders, Alzheimer's disease, nervous system disorders
05/02/2006US7037665 Compositions comprising SNORF36 receptor compounds
05/02/2006CA2334012C 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors
05/02/2006CA2173974C Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
04/2006
04/27/2006WO2006044379A2 Novel curcumin analogues and uses thereof
04/27/2006WO2006042409A1 Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cgmp phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women
04/27/2006WO2006021660A8 Use of at least one conjugated triene-containing fatty acid for preparing a medicine for treating inflammation
04/27/2006US20060089337 Estrogen replacement regimen
04/27/2006US20060089312 Protease inhibitors
04/27/2006US20060088890 Identification and isolation of somatic stem cells and uses thereof
04/27/2006US20060088580 Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved cohesion
04/27/2006CA2749235A1 Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cgmp phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women
04/27/2006CA2583943A1 Novel curcumin analogues and uses thereof
04/26/2006EP1650193A2 6-Phenylphenanthridines with PDE-IV inhibiting activity
04/26/2006EP1649760A1 Composition containing lactic acid bacterium producing equol
04/26/2006EP1648430A1 Treatment of premature ejaculation
04/26/2006EP1421377B1 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use
04/26/2006CN1764458A Bicyclic piperidine derivatives as melanocortin-4 receptor agonists
04/26/2006CN1762457A Anti-fatigue anti-senility, sexual function improving Chinese medicinal composition and its preparation method
04/26/2006CN1762429A Forsythia fruit pills formula and its preparation method
04/26/2006CN1762424A Sutellaria root pills formula and its preparation method
04/26/2006CN1762422A Process for preparing soft capsule of red sage root and notoginseng
04/26/2006CN1762394A Trogopterus dung-containing pain-relieving pill formula and its preparation method
04/26/2006CN1762366A Levonogestrel transdermal control-releasing transfer system and its multifunctional patch
04/26/2006CN1762352A Phentolamine mesylate pills and its preparation method
04/26/2006CN1762339A Contraceptive, sterilizing, virus-inhibiting medicine
04/26/2006CN1253452C Thioether subsituted imidazoquinoline compound
04/26/2006CN1253203C Proprietary Chinese traditional medicine for preventing and treating postpartum cow constitutional debility and retained afterbirth
04/26/2006CN1253202C Traditional chinese medicine for treating postpartum diseases
04/26/2006CN1253194C Externally used Shueryin lotion for treating colpitis and its preparation
04/26/2006CN1253174C Oral liquor for tonify kidney and invigorate yang
04/25/2006US7034111 17867, a novel human aminopeptidase
04/25/2006US7034041 Substituted 4-phenyl-1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridine
04/25/2006US7034034 Substituted 2-cyclohexyl-4-phenyl-1H-imidazole derivatives
04/25/2006US7034033 Substituted quinazolinone compounds
04/25/2006US7034027 Method of treating a male or female animal in the treatment of a condition where inhibition of a cGMP-specific PDE is of a therapeutic benefit comprising treating said animal with an effective amount of a pharmaceutical composition with carriers
04/25/2006US7034025 Administering to a mammal an effective dose of a cysteine derivatives containing heteroaromatic group for the treatment of arterial tension, embryogenesis, oncogenesis, diabetes, cell proliferation, and other diseases
04/25/2006US7034016 8-phenyl-6,9-dihydro-[1,2,4]triazolo[3,4-i]purin-5-one derivatives
04/25/2006US7033794 Basolateral sorting signal and inhibitors thereof
04/25/2006US7033575 Delivery of physiologically active compounds through an inhalation route
04/20/2006WO2006042104A2 Calixarene-based peptide conformation mimetics, methods of use, and methods of making
04/20/2006WO2006042021A2 Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
04/20/2006WO2006041037A1 Novel pyridine derivative
04/20/2006WO2006021655A3 Oxopiperidine derivatives, preparation and therapeutic use thereof
04/20/2006US20060084677 2-sulfo, sulfanyl, sulfinyl, sulfonyl, or sulfamyl-5-substituted-6-sulfonyl quinolines; sulfiding, oxidation, dehalogenation or aralkylation of the 6-sulfonylquinoline; selective cyclooxygenase-2 inhibitors, analgesics; side effect reduction
04/20/2006US20060084661 IL-8 receptor antagonists
04/20/2006US20060084646 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
04/20/2006US20060083792 Utilizing nanocrystalline silver metal, alloy or compound for localized tissue infections; reducing side effects; limiting overuse of antibiotics
04/20/2006US20060083784 Amorphous pharmaceutical compositions
04/20/2006US20060083740 By modulating the expression of mutant and wild type CD83 gene products produced in a mammal; regulation of T cell and dendritic cell activity; antibodies
04/20/2006US20060083733 High-concentration preparation of soluble thrombomodulin
04/20/2006DE10127897B4 Manteltablette mit Pflanzentrockenextrakten Coated tablet with dry plant extracts
04/20/2006CA2583092A1 Antiangiogenic calixarene-based peptide mimetics
04/20/2006CA2582530A1 Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
04/19/2006EP1448184B1 Use of propionyl l-carnitine or one of its pharmacologically acceptable salts for the preparation of a medicine for the treatment of la peyronie s disease
04/19/2006EP1387838B1 Cyanoanthranilamide derivatives and the use thereof as medicaments
04/19/2006EP1317428B1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors
04/19/2006EP1227820B1 Oligosaccharide aldonic acids and their topical use
04/19/2006EP1212330B1 Androgen receptor modulator compounds and methods
04/19/2006EP1143940B1 Compositions and methods for mucosal delivery
04/19/2006EP0901474B1 Aryl pyrimidine derivatives
04/19/2006CN1761680A Metastin derivative and use thereof
04/19/2006CN1761656A 3-(1-[3-(1,3-benzothiazol-6-yl)propylcarbamoyl]cycloalkyl)propanoic acid derivatives as NEP inhibitors
04/19/2006CN1761461A Compositions and methods for treatment of premature ejaculation
04/19/2006CN1759867A Granules of Chinese traditional medicine for treating women's irregular menses
04/19/2006CN1759852A Prescription of epimedium drop pills, an dpreparation method
04/19/2006CN1759850A PRescription of safflower drop pills, and preparation method
04/19/2006CN1759849A Recipe of angelica drop pills, and preparation method
04/19/2006CN1759838A Sildenafil drop pills of adjustable rate of releasing drug
04/19/2006CN1759835A Dextrose translusion of fibrauretime, and preparation method
04/19/2006CN1252239C Wine of twin ginseng and preparation method
04/19/2006CN1252071C Xanthine Phosphodiesterase V inhibitors
04/19/2006CN1252070C Urea substituted imidazoquinolines
04/19/2006CN1252065C Cinnoline compounds
04/19/2006CN1251755C Ointment for dispersing breast nodules and preparation method thereof
04/19/2006CN1251753C Externally-applied medicine composition for treating mastoproliferation and its prepn
04/19/2006CN1251748C Lotion for treating gynecological disease and its preparation process
04/19/2006CN1251736C Chinese medicinal infusion for treating shingles, parotitis acute mamitis and its manufacturing method
04/19/2006CN1251709C Health care capsule for middle aged woman
04/19/2006CN1251702C Externally applied medicine for treating women's inflammation and its prepn process
04/19/2006CN1251701C Mammary gland lobular hyperplasia treating plaster and its preparing process
04/18/2006US7030160 An agonist as beta-3 adrenergic receptors; chemical intermediates preparing through decyclization, hydroxylation; for treating gastrointestinal diseases, obesity, diabetics, psychotropic agents, nervous system disorders
04/18/2006US7030157 Hormone replacment therapy; anticancer agent; sexual disorders
04/18/2006US7030128 Imidazo-pyrimidine derivatives as ligands for GABA receptors
04/18/2006US7030123 Indole derivatives with vascular damaging activity
04/18/2006US7030104 Topical oestroprogestational compositions with a systemic effect
04/18/2006US7030089 Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione
04/18/2006US7029914 DNA encoding SNORF36 receptors
04/18/2006US7029877 binding protease thrombin to phosphoethanolamine binding protein
04/18/2006US7029708 Herbal supplement for cognitive related impairment due to estrogen loss
04/18/2006US7029658 Delivery of antidepressants through an inhalation route
04/13/2006WO2006038869A1 Probiotic lactobacillus strains for improved vaginal health
04/13/2006WO2006038680A1 2-arylcarboxamide-nitrogeneous heterocycle compound
04/13/2006WO2005116027A3 Indazole and indolone derivatives and their use as pharmaceuticals
04/13/2006US20060079692 Synthesis of indole thiazole compounds as ligands for the Ah receptor
04/13/2006US20060079548 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
04/13/2006US20060078956 Methods to identify compounds that modulate rage
04/13/2006US20060078918 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator